View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
To determine an optimal dose of AeroFact administered by nasal continuous positive airway pressure (nCPAP) versus stand of care in reducing the rate of intubation/cannulation and bolus surfactant instillation in the first 7 days after birth.
Clinical Research Coordinator: Janet Han - 510.204.1757 or e-mail: Janet.Han@sutterhealth.org
Hyper-localized Air Pollution Measures and Preterm Birth in the Bay Area
Investigators: Sylvia Sudat, PhD, External PI, Principal Investigator